<p>Indivior plc has announced the termination of registration and delisting of its ordinary shares, each with a nominal value of $0.50 per share. This move follows the company’s recent organizational changes, with Indivior plc now operating as a wholly owned subsidiary of Indivior Pharmaceuticals, Inc. As a result, Indivior plc will no longer be required to file periodic reports for its ordinary shares. The company reports only one record holder of these securities as of the notice date. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indivior plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001625297-26-000002), on January 26, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here</p>

INDV

Indivior plc Deregisters Ordinary Shares from SEC